FDA Authorizes Broad Use Of Tamiflu And Relenza To Deal With Swine Flu Outbreak
This article was originally published in The Pink Sheet Daily
Executive Summary
Emergency Use Authorizations for Roche and GSK products facilitate distribution to wider population, including alternate dosing or use by individuals outside approved labeling. FDA’s Sharfstein testifies before Congress April 30.